A photo of Francisco Flores.

Francisco X. Flores, MD


  • Medical Director, Clinical Services and MARS Program, Division of Nephrology and Hypertension
  • Associate Professor, UC Department of Pediatrics

About

Biography

Dr. Flores, received his medical degree from the University Catolica Santiago de Guayaquil in Ecuador. He completed his residency in pediatrics at the University of Miami, Jackson Memorial Hospital in Miami, Florida. Dr. Flores then completed his fellowship in pediatric nephrology at Harvard University, Boston Children’s Hospital in Boston, Massachusetts. In 1998, he started the Pediatric Nephrology Program at Tampa Children’s Hospital, in Tampa Florida and 2002, he joined the University of South Florida Morsani College of Medicine and served as an attending physician in Pediatric Nephrology at All Children’s Hospital in St. Petersburg, Florida. Over the last 14 years at All Children’s Hospital, Dr. Flores focused his clinical interest and work in the use of continuous renal replacement therapy in pediatric acute kidney injury; and in 2008 he became the director of the CRRT Program at this institution. In 2011, Dr. Flores developed the Molecular Adsorbent Recirculating System (MARS) Program at All Children’s Hospital, which at that time became the second pediatric program in the US and the only program in Florida that provided supportive therapy to children with drug overdose, poisoning and acute liver failure.

In June of 2016, Dr. Flores joined the Division of Pediatric Nephrology and Hypertension as the medical director of clinical services and the MARS Program at Cincinnati Children’s Hospital Medical Center.

Dr. Flores’ areas of clinical interest include acute kidney injury, the use of continuous renal replacement therapy and the use of MARS in pediatric patients.

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis. Chalhoub, NE; Wenderfer, SE; Levy, DM; Rouster-Stevens, K; Aggarwal, A; Savani, SI; Ruth, NM; Arkachaisri, T; Qiu, T; Merritt, A; et al. Arthritis and Rheumatology. 2022; 74:263-273.

Primary hyperoxaluria diagnosed after kidney transplant: A review of the literature and case report of aggressive renal replacement therapy and lumasiran to prevent allograft loss. Stone, HK; VandenHeuvel, K; Bondoc, A; Flores, FX; Hooper, DK; Varnell, CD. American Journal of Transplantation. 2021; 21:4061-4067.

Glomerular Hyperfiltration Is Associated with Liver Disease Severity in Children with Nonalcoholic Fatty Liver Disease. Yodoshi, T; Arce-Clachar, AC; Sun, Q; Fei, L; Bramlage, K; Xanthakos, SA; Flores, F; Mouzaki, M. Journal of Pediatrics. 2020; 222:127-133.

Evaluation of a change in cytomegalovirus prevention strategy following pediatric solid organ transplantation. Pangonis, S; Paulsen, G; Andersen, H; Flores, F; Miethke, A; Peters, A; Kocoshis, S; Lazear, D; Garr, B; Schecter, M; et al. Transplant Infectious Disease. 2020; 22.

American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus. Brunner, HI; Holland, MJ; Beresford, MW; Ardoin, SP; Appenzeller, S; Silva, CA; Flores, F; Aydin, PO A; Wenderfer, SE; Levy, DM; et al. Arthritis Care and Research. 2019; 71:579-590.

Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus Erythematosus. Holland, MJ; Beresford, MW; Feldman, BM; Huggins, J; Norambuena, X; Silva, CA; Susic, G; Sztajnbok, F; Uziel, Y; Appenzeller, S; et al. Arthritis Care and Research. 2018; 70:1621-1629.

Management Considerations for the Delivery of CRRT in Children. Flores, FX. Critical Care Nephrology and Renal Replacement Therapy in Children. 2018.

American College of Rheumatology Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus. Brunner, HI; Holland, M; Beresford, MW; Ardoin, SP; Appenzeller, S; Silva, CA; Flores, F; Goilav, B; Wenderfer, SE; Levy, DM; et al. Arthritis Care and Research. 2018; 70:813-822.

Management considerations for the delivery of crrt in children. Flores, FX. Critical Care Nephrology and Renal Replacement Therapy in Children. 2018.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey